EAST END GROUP, LLC

Lobbying for LONGHORN · Vaccine and diagnostic development and manufacturing.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Maryland · House · Senate · $60,000.00 income · posted Oct 17, 2025

Lobbying activity 1

Health Issues

Reauthorization of the Pandemic and All-Hazards Preparedness Act, legislative and regulatory issues related to vaccine and diagnostic research, development and stockpiling. LHHS preparedness appropriations.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.